Technology | November 20, 2017

Eizo RadiForce RX560 Monitor Receives FDA 510(k) for Tomosynthesis and Digital Mammography

Five-megapixel monitor displays both monochrome and color images in high detail

Eizo RadiForce RX560 Monitor Receives FDA 510(k) for Tomosynthesis and Digital Mammography

November 20, 2017 — Eizo Corp. announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for breast tomosynthesis and digital mammography for its 5-megapixel color medical monitor, the RadiForce RX560.

Watch the VIDEO Eizo Introduces the RadiForce RX560 at RSNA 2017.

Breast cancer screenings increasingly combine the use of mammography and ultrasound to view patients with high breast density. Furthermore, if breast cancer is suspected, various other tests may also be needed such as biopsy, breast magnetic resonance imaging (MRI) and computed tomography (CT). Because of this, monitors that can accurately display tomosynthesis, mammography and general radiology are becoming increasingly important.

The RX560 is the world's first medical monitor to use a low temperature polysilicon (LTPS) liquid crystal display, according to Eizo. Because of this, the color monitor can reach a brightness of up to 1100 cd/m2, similar to that of monochrome monitors. In order to detect the smallest structures within breast tissue, the monitor offers a high contrast ratio of 1,500:1. Furthermore the monitor has a response time of 12 milliseconds, making it ideal for enlarging and panning medical images, as well as quickly displaying 3-D breast tomosynthesis which is comprised of several images in each shot. The 5 megapixel (2,048 x 2,560) resolution is ideal for viewing the fine details in breast images.

The RX560 is able to display both monochrome and color medical images on the same screen due to the Hybrid Gamma PXL function included with the monitor. With this function, both monochrome and color images are set to the optimum grayscale and gamma curve pixel-by-pixel, improving the efficiency of interpretation work.  

Eizo will demonstrate the RadiForce RX560 at the 103rd Radiological Society of North America Annual Meeting (RSNA 2017), Nov. 26-Dec. 1 in Chicago.

For more information: www.eizo.com

Related Content

Hologic Opens Learning and Experience Centre in Zaventem, Belgium
News | Women's Health | March 21, 2019
Hologic Inc. opened its first Learning and Experience Centre in Zaventem, Belgium. The state-of-the-art facility...
QTbreasthealth Opens Breast Imaging Center in San Jose
News | Ultrasound Women's Health | March 20, 2019
QTbreasthealth has opened a new center in San Jose, Calif. The new location is now open and booking appointments for...
Older Biologic Age Linked to Elevated Breast Cancer Risk
News | Women's Health | March 19, 2019
Biologic age, a DNA-based estimate of a person’s age, is associated with future development of breast cancer, according...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Fujifilm Launches Three New Software Tools for Aspire Cristalle Digital Mammography System
Technology | Mammography | March 15, 2019
Fujifilm Medical Systems USA announced it has fulfilled all U.S. Food and Drug Administration (FDA) regulatory...
Hologic Receives CE Mark for Three-in-One Omni Hysteroscope
News | Endoscopes | March 14, 2019
Hologic Inc. announced it has received a CE mark in Europe for its Omni hysteroscope, a three-in-one modular scope with...
CT, Mammograms Offer Clues to Preventing Heart Problems After Cancer Treatment
News | Cardio-oncology | March 13, 2019
An imaging procedure commonly performed before starting cancer treatment can provide valuable clues about a patient's...
Sponsored Content | Videos | Artificial Intelligence | March 13, 2019
At RSNA 2018, iCad showed how its...
Hologic Earns CE Mark for LOCalizer Wireless Breast Lesion Localization System
News | Breast Imaging | March 07, 2019
Hologic Inc. announced the granting of a CE Mark to the LOCalizer wireless radio frequency identification (RFID) breast...
South Dakota's Density Inform Bill Signed Into Law
News | Breast Density | March 06, 2019
With the passage of HB1124, South Dakota becomes the 37th state with breast density inform legislation. The law, which...